VitaPurity offers you only 100% pure natural medicines and nutritional supplements at deeply discounted prices delivered right to your door!

Ellagic Acid: References

Tannins, xenobiotic metabolism and cancer chemoprevention in experimental animals. 
  Nepka C, Asprodini E, Kouretas D 
  Eur J Drug Metab Pharmacokinet; 24(2):183-9 1999    UI: 99440448
The effects of ellagic acid on arylamine N-acetyltransferase activity in the bacterium Pseudomonas aeruginosa. 
  Lo HH, Hsieh SE, Tsai KJ, Chung JG 
  Drug Chem Toxicol; 22(3):555-62 1999    UI: 99374190
Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice. 
  Khanduja KL, Gandhi RK, Pathania V, Syal N 
  Food Chem Toxicol; 37(4):313-8 1999    UI: 99345316
p53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. 
  Narayanan BA, Geoffroy O, Willingham MC, Re GG, Nixon DW 
  Cancer Lett; 136(2):215-21 1999    UI: 99281882
Determining efficacy of cancer chemopreventive agents using a cell-free system concomitant with DNA adduction. 
  Smith WA, Gupta RC 
  Mutat Res; 425(1):143-52 1999    UI: 99185178
Isothiocyanates and freeze-dried strawberries as inhibitors of esophageal cancer. 
  Stoner GD, Kresty LA, Carlton PS, Siglin JC, Morse MA 
  Toxicol Sci; 52(2 Suppl):95-100 1999    UI: 20094292
Protective effect of curcumin, ellagic acid and bixin on radiation induced genotoxicity. 
  Thresiamma KC, George J, Kuttan R 
  J Exp Clin Cancer Res; 17(4):431-4 1998    UI: 99186924
Polyphenols inhibit promotional phase of tumorigenesis: relevance of superoxide radicals. 
  Kaul A, Khanduja KL 
  Nutr Cancer; 32(2):81-5 1998    UI: 99118269
Effects of dietary anticarcinogens on rat gastrointestinal glutathione S-transferase theta 1-1 levels. 
  van Lieshout EM, Bedaf MM, Pieter M, Ekkel C, Nijhoff WA, Peters WH 
  Carcinogenesis; 19(11):2055-7 1998    UI: 99070666
10  Biodistribution of, antimutagenic efficacies in Salmonella typhimurium of, and inhibition of P450 activities by ellagic acid and one analogue. 
  Castonguay A, Boukharta M, Teel R 
  Chem Res Toxicol; 11(11):1258-64 1998    UI: 99034533
11  In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. 
  Soliman KF, Mazzio EA 
  Proc Soc Exp Biol Med; 218(4):390-7 1998    UI: 98377887
12  [Phenolic acid intake of adults in a Bavarian subgroup of the national food consumption survey] 
  Radtke J, Linseisen J, Wolfram G 
  Z Ernahrungswiss; 37(2):190-7 1998    UI: 98363803
13  [The protective action of ellagic acid in experimental myocarditis] 
  Iakovleva LV, Ivakhnenko AK, Buniatian ND 
  Eksp Klin Farmakol; 61(3):32-4 1998    UI: 98354527
14  Effect of cancer chemopreventive agents on microsome-mediated DNA adduction of the breast carcinogen dibenzo[a,l]pyrene. 
  Smith WA, Arif JM, Gupta RC 
  Mutat Res; 412(3):307-14 1998    UI: 98261326
15  Modulation of dibenzo[a,l]pyrene-DNA adduction by chemopreventive agents in the human breast epithelial cell line MCF-7 (Meeting abstract). 
  Smith WA, Freeman JW, Gupta RC 
  Proc Annu Meet Am Assoc Cancer Res; 38:A2422 1997    UI: 98639422
16  Ellagic acid induces oxidative inactivation of protein kinase C by modifying both catalytic and regulatory domains (Meeting abstract). 
  Chen Z, Gundimeda U, Gopalakrishna R 
  Proc Annu Meet Am Assoc Cancer Res; 38:A1395 1997    UI: 98638395
17  Modulation of TCDD-induced fetotoxicity and oxidative stress in embryonic and placental tissues of C57BL/6J mice by vitamin E succinate and ellagic acid. 
  Hassoun EA, Walter AC, Alsharif NZ, Stohs SJ 
  Toxicology; 124(1):27-37 1997    UI: 98052346
18  Mechanism of action of fotemustine, a new chloroethylnitrosourea anticancer agent: evidence for the formation of two DNA-reactive intermediates contributing to cytotoxicity. 
  Hayes MT, Bartley J, Parsons PG, Eaglesham GK, Prakash AS 
  Biochemistry; 36(35):10646-54 1997    UI: 97419128
19  Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity. 
  Soni KB, Lahiri M, Chackradeo P, Bhide SV, Kuttan R 
  Cancer Lett; 115(2):129-33 1997    UI: 97293062
20  Isothiocyanates and plant polyphenols as inhibitors of lung and esophageal cancer. 
  Stoner GD, Morse MA 
  Cancer Lett; 114(1-2):113-9 1997    UI: 97256427
21  Experimental evidence for cancer preventive elements in foods.  
  Wargovich MJ 
  Cancer Lett; 114(1-2):11-7 1997    UI: 97256404
22  Effects of chemopreventive agents on bioactivation of benzo[a]pyrene (BP) and dibenzo[a,l]pyrene (DBP) as measured via DNA adduction (Meeting abstract). 
  Smith WA, Arif JM, Gupta RC 
  Proc Annu Meet Am Assoc Cancer Res; 37:1874 1996    UI: 97609998
23  Organ specific, protocol dependent modulation of 7,12-dimethylbenz[a]anthracene carcinogenesis in rainbow trout (Oncorhynchus mykiss) by dietary ellagic acid. 
  Harttig U, Hendricks JD, Stoner GD, Bailey GS 
  Carcinogenesis; 17(11):2403-9 1996    UI: 97122435
24  Chemoprevention of colorectal cancer. 
  Krishnan K, Brenner DE 
  Gastroenterol Clin North Am; 25(4):821-58 1996    UI: 97120224
25  Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention. 
  Eaton EA, Walle UK, Lewis AJ, Hudson T, Wilson AA, Walle T 
  Drug Metab Dispos; 24(2):232-7 1996    UI: 96351686
26  Modulation of the mutagenicity and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by phenolic compounds. 
  Miller C, Castonguay A, Teel RW 
  Mutat Res; 368(3-4):221-33 1996    UI: 96305502
27  Use of a microsome-mediated test system to assess efficacy and mechanisms of cancer chemopreventive agents. 
  Smith WA, Gupta RC 
  Carcinogenesis; 17(6):1285-90 1996    UI: 96281687
28  Structure-function relationships of the dietary anticarcinogen ellagic acid. 
  Barch DH, Rundhaugen LM, Stoner GD, Pillay NS, Rosche WA 
  Carcinogenesis; 17(2):265-9 1996    UI: 96225897
29  Anti-genotoxic effects in mice after the interaction between coffee and dietary constituents. 
  Abraham SK 
  Food Chem Toxicol; 34(1):15-20 1996    UI: 96190851
30  Anticarcinogenic phase 2 enzyme inducers in edible plants (Meeting abstract). 
  Talalay P, Fahey JW, Prestera T, Wade KL, Zhang Y 
  Proc Annu Meet Am Assoc Cancer Res; 36:703-4 1995    UI: 96604754
31  Use of a microsomal activation system as a potential screening method for cancer chemopreventive agents (Meeting abstract). 
  Smith WA, Devanaboyina U, Gupta RC 
  Proc Annu Meet Am Assoc Cancer Res; 36:A3555 1995    UI: 96602508
32  Biological activity of diet-derived flavonoids: effects on pS2 expression and cellular proliferation (Meeting abstract). 
  Sathyamoorthy N, Wang TT, Do LD, Phang JM 
  Proc Annu Meet Am Assoc Cancer Res; 36:A3548 1995    UI: 96600277
33  Chemoprevention of diethylnitrosamine-induced liver foci and hepatocellular adenomas in C3H mice. 
  Pereira MA 
  Anticancer Res; 15(5B):1953-6 1995    UI: 96152424
34  Pentachlorophenol-induced oxidative DNA damage in mouse liver and protective effect of antioxidants. 
  Sai-Kato K, Umemura T, Takagi A, Hasegawa R, Tanimura A, Kurokawa Y 
  Food Chem Toxicol; 33(10):877-82 1995    UI: 96077171
35  Regional chemoprevention of carcinogen-induced tumors in rat colon. 
  Liu T, Mokuolu AO, Rao CV, Reddy BS, Holt PR 
  Gastroenterology; 109(4):1167-72 1995    UI: 96029317
36  Polyphenols as cancer chemopreventive agents. 
  Stoner GD, Mukhtar H 
  J Cell Biochem Suppl; 22:169-80 1995    UI: 96010329
37  Tumor suppression and anti-initiation by dietary ellagic acid against 7,12-dimethylbenz[a]anthracene (DMBA) in rainbow trout (Meeting abstract). 
  Harttig U, Stoner G, Bailey G 
  Proc Annu Meet Am Assoc Cancer Res; 36:A739 1995    UI: 95608518
38  Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. 
  Menon LG, Kuttan R, Kuttan G 
  Cancer Lett; 95(1-2):221-5 1995    UI: 95384993
39  The dietary anticancer agent ellagic acid is a potent inhibitor of DNA topoisomerases in vitro. 
  Constantinou A, Stoner GD, Mehta R, Rao K, Runyan C, Moon R 
  Nutr Cancer; 23(2):121-30 1995    UI: 95372233
40  Modulating effects of ellagic acid, vanillin and quercetin in a rat medium term multi-organ carcinogenesis model. 
  Akagi K, Hirose M, Hoshiya T, Mizoguchi Y, Ito N, Shirai T 
  Cancer Lett; 94(1):113-21 1995    UI: 95346911
41  Effects of dietary phenethyl isothiocyanate, ellagic acid, sulindac and calcium on the induction and progression of N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. 
  Siglin JC, Barch DH, Stoner GD 
  Carcinogenesis; 16(5):1101-6 1995    UI: 95285520
42  Ellagic acid induces transcription of the rat glutathione S-transferase-Ya gene. 
  Barch DH, Rundhaugen LM, Pillay NS 
  Carcinogenesis; 16(3):665-8 1995    UI: 95211955
43  Chemoprevention of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP)-induced mammary gland carcinogenesis by antioxidants in F344 female rats. 
  Hirose M, Akagi K, Hasegawa R, Yaono M, Satoh T, Hara Y, Wakabayashi K, Ito N 
  Carcinogenesis; 16(2):217-21 1995    UI: 95163168
44  Food phytochemicals for cancer prevention I: fruits and vegetables 
  Huang MT, Osawa T, Ho CT, Rosen RT 
  ACS Symp Ser; 546:1-427 1994    UI: 96603729
45  Inhibition of NNK mutagenesis and metabolism by chemopreventive phytochemicals. 
  Miller CH 
  Diss Abstr Int [B]; 55(6):2119 1994    UI: 95615369
46  Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo[4,5-f]quinoline in the rat. 
  Tsuda H, Uehara N, Iwahori Y, Asamoto M, Iigo M, Nagao M, Matsumoto K, Ito M, Hirono I 
  Jpn J Cancer Res; 85(12):1214-9 1994    UI: 95155154
47  Ellagic acid induces NAD(P)H:quinone reductase through activation of the antioxidant responsive element of the rat NAD(P)H:quinone reductase gene. 
  Barch DH, Rundhaugen LM 
  Carcinogenesis; 15(9):2065-8 1994    UI: 95008026
48  Quantification of induction of rat oesophageal, gastric and pancreatic glutathione and glutathione S-transferases by dietary anticarcinogens. 
  Nijhoff WA, Peters WH 
  Carcinogenesis; 15(9):1769-72 1994    UI: 95007981
49  Screening for agents inhibiting the mutagenicity of extracts and constituents of tobacco products. 
  Romert L, Jansson T, Curvall M, Jenssen D 
  Mutat Res; 322(2):97-110 1994    UI: 94322845
50  Identification of tricyclic analogs related to ellagic acid as potent/selective tyrosine protein kinase inhibitors. 
  Dow RL, Chou TT, Bechle BM, Goddard C, Larson ER 
  J Med Chem; 37(14):2224-31 1994    UI: 94309076
51  Chemoprevention of cancer. 
  Szarka CE, Grana G, Engstrom PF 
  Curr Probl Cancer; 18(1):6-79 1994    UI: 94273543
52  Chemopreventive drug development: perspectives and progress. 
  Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet R, Sigman CC 
  Cancer Epidemiol Biomarkers Prev; 3(1):85-98 1994    UI: 94163105
53  Food and cancer prevention: chemical and biological aspects. 
  Anonymous 
  Non-serial; Food and Cancer Prevention: Chemical and Biological Aspects. Waldron KW, Johnson IT, Fenwick GR, eds. Cambridge, UK, Royal Society of Chemistry, 461 p., 1993.: 1993    UI: 95616078
54  Cancer chemoprevention. 
  Anonymous 
  Non-serial; Cancer Chemoprevention. Wattenberg L, Lipkin M, Boone WB, et al, eds., Boca Raton, FL, CRC Press, 630 p., 1993.: 1993    UI: 95606775
55  Chemoprevention drug development: perspectives and progress (Meeting abstract) 
  Kelloff GJ, Boone CW, Malone WF, Crowell JA, Steele VE, Perloff M, Sigman CC 
  Non-serial; Anticarcinogenesis and Radiation Protection, 4th International Conference: Mechanisms, Biomarkers, Molecular Diagnostics and Preventive Strategies. April 18-23, 1993, Baltimore, Maryland, p. 63, 1993.: 1993    UI: 94699779
56  Chemoprevention drug development at the National Cancer Institute (Meeting abstract). 
  Kelloff GJ, Boone CW, Steele V, Perloff M, Crowell JA 
  Non-serial; Current Strategies of Cancer Chemoprevention, 13th International Symposium on Cancer. July 6-9, 1993, Sapporo, Japan, p. 11, 1993.: 1993    UI: 94699212
57  Chemoprevention drug development: preclinical studies and Phase II clinical trials (Meeting abstract). 
  Kelloff GJ, Boone CW, Malone WF, Steele V, Perloff M, Crowell JA 
  Non-serial; CCPC-93: Second International Cancer Chemo Prevention Conference. April 28-30, 1993, Berlin, Germany, p. 46, 1993.: 1993    UI: 94696733
58  Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid. 
  Zhang Z, Hamilton SM, Stewart C, Strother A, Teel RW 
  Anticancer Res; 13(6A):2341-6 1993    UI: 94127867
59  Comparative cytotoxicities of selected minor dietary non-nutrients with chemopreventive properties. 
  Babich H, Borenfreund E, Stern A 
  Cancer Lett; 73(2-3):127-33 1993    UI: 94036760
60  Lung tumors in strain A mice: application for studies in cancer chemoprevention. 
  Stoner GD, Adam-Rodwell G, Morse MA 
  J Cell Biochem Suppl; 17F:95-103 1993    UI: 94017849
61  Protective effects of antioxidants against endrin-induced hepatic lipid peroxidation, DNA damage, and excretion of urinary lipid metabolites. 
  Bagchi D, Hassoun EA, Bagchi M, Stohs SJ 
  Free Radic Biol Med; 15(2):217-22 1993    UI: 93387736
62  Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. 
  Tanaka T, Kojima T, Kawamori T, Wang A, Suzui M, Okamoto K, Mori H 
  Carcinogenesis; 14(7):1321-5 1993    UI: 93321268
63  Ellagic acid embryoprotection in vitro: distribution and effects on DNA adduct formation. 
  Frank AA, Collier JM, Forsyth CS, Zeng W, Stoner GD 
  Teratology; 47(4):275-80 1993    UI: 93310697
64  Pulmonary carcinogenesis and its prevention by dietary polyphenolic compounds. 
  Castonguay A 
  Ann N Y Acad Sci; 686:177-85 1993    UI: 93290257
65  Cellular and molecular targets for chemoprevention. 
  Anonymous 
  Non-serial; Cellular and Molecular Targets for Chemoprevention. Steele VE, Stoner GD, Boone CW et al, eds. Boca Raton, FL, CRC, 373 p., 1992.: 1992    UI: 95606652
66  Synthesis of ellagic acid O-alkyl derivatives and isolation of ellagic acid as a tetrahexanoyl derivative from Fragaria ananassa. 
  Heur YH, Zeng W, Stoner GD, Nemeth GA, Hilton B 
  J Nat Prod; 55(10):1402-7 1992    UI: 93085361
67  Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice. 
  Boukharta M, Jalbert G, Castonguay A 
  Nutr Cancer; 18(2):181-9 1992    UI: 93065413
68  Antitumor-promoting activities of tannic acid, ellagic acid, and several gallic acid derivatives in mouse skin. 
  Perchellet JP, Gali HU, Perchellet EM, Klish DS, Armbrust AD 
  Basic Life Sci; 59:783-801 1992    UI: 93038465
69  Hydrolyzable tannins: potent inhibitors of hydroperoxide production and tumor promotion in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate in vivo. 
  Gali HU, Perchellet EM, Klish DS, Johnson JM, Perchellet JP 
  Int J Cancer; 51(3):425-32 1992    UI: 92275855
70  Antitumor-promoting activities of hydrolyzable tannins in mouse skin. 
  Gali HU, Perchellet EM, Klish DS, Johnson JM, Perchellet JP 
  Carcinogenesis; 13(4):715-8 1992    UI: 92248811
71  Sequence-selective depurination, DNA interstrand cross-linking and DNA strand break formation associated with alkylated DNA. 
  Prakash AS, Gibson NW 
  Carcinogenesis; 13(3):425-31 1992    UI: 92191383
72  CHEMOPREVENTION BY NONNUTRIENT COMPONENTS OF VEGETABLES AND FRUITS 
  Birt DF, Bresnick E 
  Hum Nutr: A Compr Treatise; 7:221-60 1991    UI: 92686046
73  Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon. 
  Pereira MA, Khoury MD 
  Cancer Lett; 61(1):27-33 1991    UI: 92110784
74  The crystal and molecular structure of ellagic acid dihydrate: a dietary anti-cancer agent [published erratum appears in Carcinogenesis 1992 Mar;13(3):513] 
  Rossi M, Erlebacher J, Zacharias DE, Carrell HL, Iannucci B 
  Carcinogenesis; 12(12):2227-32 1991    UI: 92083608
75  QUANTITATION AND LIBERATION OF ELLAGIC ACID IN DIETARY SOURCES, AND ITS EFFECTS, IN COMBINATION WITH 13-CIS RETINOIC ACID, ON THE DEVELOPMENT OF N-NITROSOBENZYLMETHYLAMINE-INDUCED ESOPHAGEAL TUMORS IN F344 RATS 
  Daniel EM 
  Diss Abstr Int [B]; 51(10):4787 1991    UI: 91676344
76  Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. 
  Rao CV, Tokumo K, Rigotty J, Zang E, Kelloff G, Reddy BS 
  Cancer Res; 51(17):4528-34 1991    UI: 91339132
77  Lung tumorigenicity of NNK given orally to A/J mice: its application to chemopreventive efficacy studies. 
  Castonguay A, Pepin P, Stoner GD 
  Exp Lung Res; 17(2):485-99 1991    UI: 91266816
78  Inhibition of tumor promoter-induced ornithine decarboxylase activity by tannic acid and other polyphenols in mouse epidermis in vivo. 
  Gali HU, Perchellet EM, Perchellet JP 
  Cancer Res; 51(11):2820-5 1991    UI: 91235179
79  The effects of ellagic acid and 13-cis-retinoic acid on N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats. 
  Daniel EM, Stoner GD 
  Cancer Lett; 56(2):117-24 1991    UI: 91152701
80  Combination of blocking agents and suppressing agents in cancer prevention. 
  Ip C, Ganther HE 
  Carcinogenesis; 12(2):365-7 1991    UI: 91138220
81  FOOD MUTAGENS: FACTORS THAT MODULATE THEIR METABOLIC ACTIVATION 
  Ayrton AD 
  Diss Abstr Int [B]; 50(12):5398 1990    UI: 90666780
82  The effect of retinoids, carotenoids and phenolics on chromosomal instability of bovine papillomavirus DNA-carrying cells. 
  Stich HF, Tsang SS, Palcic B 
  Mutat Res; 241(4):387-93 1990    UI: 90331956
83  Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents. 
  Steele VE, Kelloff GJ, Wilkinson BP, Arnold JT 
  Cancer Res; 50(7):2068-74 1990    UI: 90199728
84  Inhibition of N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid. 
  Mandal S, Stoner GD 
  Carcinogenesis; 11(1):55-61 1990    UI: 90106890
85  Ellagic acid effects on the carcinogenicity, DNA-binding and metabolism of 7,12-dimethylbenz(a)anthracene (DMBA). 
  Singletary K, Liao CH 
  In Vivo; 3(3):173-5 1989    UI: 92135639
86  INHIBITION OF N-NITROSAMINE CARCINOGENESIS AND AFLATOXIN DNA DAMAGE BY ELLAGIC ACID 
  Mandal-Chaudhuri S 
  Diss Abstr Int [B]; 49(7):2577 1989    UI: 89655083
87  Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster respiratory tissues cultured with ellagic acid [published erratum appears in Cancer Lett 1989 Sep 15;47(1-2):161] 
  Castonguay A, Allaire L, Charest M, Rossignol G, Boutet M 
  Cancer Lett; 46(2):93-105 1989    UI: 89323981
88  Comparative studies of the inhibitory properties of antibiotics on human immunodeficiency virus and avian myeloblastosis virus reverse transcriptases and cellular DNA polymerases. 
  Take Y, Inouye Y, Nakamura S, Allaudeen HS, Kubo A 
  J Antibiot (Tokyo); 42(1):107-15 1989    UI: 89155329
89  Dietary ellagic acid reduces the esophageal microsomal metabolism of methylbenzylnitrosamine. 
  Barch DH, Fox CC 
  Cancer Lett; 44(1):39-44 1989    UI: 89135843
90  Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats. 
  Tanaka T, Iwata H, Niwa K, Mori Y, Mori H 
  Jpn J Cancer Res; 79(12):1297-303 1988    UI: 89174199
91  Dietary inhibitors of mutagenesis and carcinogenesis. 
  Hayatsu H, Arimoto S, Negishi T 
  Mutat Res; 202(2):429-46 1988    UI: 89057035
92  Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4. 
  Dumenco LL, Everson B, Culp LA, Ratnoff OD 
  J Lab Clin Med; 112(3):394-400 1988    UI: 88316031
93  Inhibition of N-nitrosobenzylmethylamine metabolism and DNA binding in cultured rat esophagus by ellagic acid. 
  Mandal S, Shivapurkar NM, Galati AJ, Stoner GD 
  Carcinogenesis; 9(7):1313-6 1988    UI: 88253661
94  Inhibition of aflatoxin B1 mutagenesis in Salmonella typhimurium and DNA damage in cultured rat and human tracheobronchial tissues by ellagic acid. 
  Mandal S, Ahuja A, Shivapurkar NM, Cheng SJ, Groopman JD, Stoner GD 
  Carcinogenesis; 8(11):1651-6 1987    UI: 88027529
95  Ellagic acid toxicity and interaction with benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol in human bronchial epithelial cells. 
  Teel RW, Babcock MS, Dixit R, Stoner GD 
  Cell Biol Toxicol; 2(1):53-62 1986    UI: 90002322
96  AMERICAN SOCIETY OF PREVENTIVE ONCOLOGY. MARCH 5-7, 1986, BETHESDA, MD 
  Anonymous 
  Non-serial; American Society of Preventive Oncology. March 5-7, 1986, Bethesda, MD, 1986.: 1986    UI: 87630260
97  Effect of ellagic acid and 3-O-decylellagic acid on the formation of benzo[a]pyrene-derived DNA adducts in vivo and on the tumorigenicity of 3-methylcholanthrene in mice. 
  Smart RC, Huang MT, Chang RL, Sayer JM, Jerina DM, Wood AW, Conney AH 
  Carcinogenesis; 7(10):1669-75 1986    UI: 87002893
98  Disposition of the naturally occurring antimutagenic plant phenol, ellagic acid, and its synthetic derivatives, 3-O-decylellagic acid and 3,3'-di-O-methylellagic acid in mice. 
  Smart RC, Huang MT, Chang RL, Sayer JM, Jerina DM, Conney AH 
  Carcinogenesis; 7(10):1663-7 1986    UI: 87002892
99  Pharmacological modification of epidermal detoxification systems. 
  Bickers DR, Das M, Mukhtar H 
  Br J Dermatol; 115 Suppl 31:9-16 1986    UI: 86296561
100  Inhibition of 3-methylcholanthrene-induced skin tumorigenicity in BALB/c mice by chronic oral feeding of trace amounts of ellagic acid in drinking water. 
  Mukhtar H, Das M, Bickers DR 
  Cancer Res; 46(5):2262-5 1986    UI: 86189522
101  Ellagic acid binding to DNA as a possible mechanism for its antimutagenic and anticarcinogenic action. 
  Teel RW 
  Cancer Lett; 30(3):329-36 1986    UI: 86189483
102  Evaluation of anti-inflammatory agents using a model of granuloma formation evoked by divinyl copolymer beads in the mouse lung. 
  Coleman SE, Hood CI, Schoen FJ, Rheinhardt JM 
  J Biomed Mater Res; 20(3):301-14 1986    UI: 86168363
103  Combined effects of butylated hydroxyanisole and other antioxidants in induction of forestomach lesions in rats. 
  Hirose M, Hagiwara A, Masui T, Inoue K, Ito N 
  Cancer Lett; 30(2):169-74 1986    UI: 86161442
104  Effect of ellagic acid on hepatic and pulmonary xenobiotic metabolism in mice: studies on the mechanism of its anticarcinogenic action. 
  Das M, Bickers DR, Mukhtar H 
  Carcinogenesis; 6(10):1409-13 1985    UI: 86002623
105  Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse. 
  Chang RL, Huang MT, Wood AW, Wong CQ, Newmark HL, Yagi H, Sayer JM, Jerina DM, Conney AH 
  Carcinogenesis; 6(8):1127-33 1985    UI: 85255346
106  Inhibition of benzo(a)pyrene and benzo(a)pyrene-trans-7,8-diol metabolism and DNA binding in mouse lung explants by ellagic acid. 
  Dixit R, Teel RW, Daniel FB, Stoner GD 
  Cancer Res; 45(7):2951-6 1985    UI: 85227981
107  Spontaneous fibrinolysis in whole human plasma. Identification of tissue activator-related protein as the major plasminogen activator causing spontaneous activity in vitro. 
  Wun TC, Capuano A 
  J Biol Chem; 260(8):5061-6 1985    UI: 85182630
108  Effect of ellagic and caffeic acids on covalent binding of benzo[a]pyrene to epidermal DNA of mouse skin in organ culture. 
  Shugart L, Kao J 
  Int J Biochem; 16(5):571-3 1984    UI: 84209314
109  Protection against 3-methylcholanthrene-induced skin tumorigenesis in Balb/C mice by ellagic acid. 
  Mukhtar H, Das M, Del Tito BJ Jr, Bickers DR 
  Biochem Biophys Res Commun; 119(2):751-7 1984    UI: 84178448
110  Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene-induced neoplasia in mice. 
  Lesca P 
  Carcinogenesis; 4(12):1651-3 1983    UI: 84082484
111  Inhibition of epidermal metabolism and DNA-binding of benzo[a]pyrene by ellagic acid. 
  Del Tito BJ Jr, Mukhtar H, Bickers DR 
  Biochem Biophys Res Commun; 114(1):388-94 1983    UI: 83282781
112  Inability of several mutagen-blocking agents to inhibit 1,2-dimethylhydrazine-induced DNA-damaging activity in colonic epithelium. 
  Wargovich MJ, Newmark HL 
  Mutat Res; 121(1):77-80 1983    UI: 83244824
113  INHIBITION OF THE MUTAGENICITY OF BAY-REGION DIOL EPOXIDES OF POLYCYCLIC AROMATIC HYDROCARBONS BY NATURALLY OCCURRING PLANT PHENOLS: EXCEPTIONAL ACTIVITY OF ELLAGIC ACID 
  Wood AW, Huang MT, Chang RL, Newmark HL, Lehr RE, Yagi H, Sayer JM, Jerina DM, Conney AH 
  Proc Natl Acad Sci U S A; 79(18):5513-5517 1982    UI: 82631054
114  PLASMA PREKALLIKREIN (FLETCHER FACTOR) DEFICIENCY IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA 
  Waddell CC, Brown JA, Udden MM 
  South Med J; 73(12):1653-1655 1980    UI: 81695551
115  [INFLUENCE OF ELLAGIC ACID AND HEPARIN ON COAGULATION, FIBRINOLYSIS AND METASTASIS IN TRAUMATIZED ANIMALS] 
  Agostino D, Agostino N 
  Sangre (Barc); 25(6):989-998 1980    UI: 81613131
116  [Influence of ellagic acid and heparin on coagulation, fibrinolysis and metastasis in traumatized animals (author's transl)] 
  Agostino D, Agostino N 
  Sangre (Barc); 25(6):989-98 1980    UI: 81177563
117  Enhancement of pulmonary metastases following the intravenous infusion of a suspension of ellagic acid in traumatized rats. 
  Agostino D, Agostino N 
  Tumori; 66(3):285-93 1980    UI: 81080289
118  Plasma prekallikrein (Fletcher factor) deficiency in a patient with chronic lymphocytic leukemia. 
  Waddell CC, Brown JA, Udden MM 
  South Med J; 73(12):1653-5 1980    UI: 81078975
119  ENHANCEMENT OF PULMONARY METASTASES FOLLOWING THE INTRAVENOUS INFUSION OF A SUSPENSION OF ELLAGIC ACID IN TRAUMATIZED RATS 
  Agostino D, Agostino N 
  Tumori; 66(3):285-293 1980    UI: 80676502
120  EFFECT OF TANNIC ACID AND ELLAGIC ACID ON THE INFECTIVITY OF POTATO VIRUS X IN TISSUE CULTURE 
  Verma VS, Raychaudhuri SP 
  Naturwissenschaften; 55(11):546 1968    UI: 69700990
121  ANTITUMOR ACTIVITY OF JUGLANS NIGRA (BLACK WALNUT) EXTRACTIVES  
  Bhargava UC, Westfall BA 
  J Pharm Sci; 57(10):1674-1677 1968    UI: 68801494
122  [EFFECT OF ELLAGIC ACID ON THE INDUCTION AND DEVELOPMENT OF SOLID I.R.E. RETICULUM CELL SARCOMA]
  Fumarola D, Maruccio L, Restuccia P 
  Haematologica; 52(9):701-706 1967    UI: 69701760